Clinical Trial Update: Cytoflavin in the Rehabilitation of Post-intensive Care Syndrome in Stroke Survivors

View source ↗

Summary

A completed clinical trial evaluating Cytoflavin for rehabilitation in ischemic stroke patients with post-intensive care syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-intensive Care Syndrome
• Stroke

Drugs mentioned

• Cytoflavin

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Ischemic Stroke, Post Intensive Care Unit Syndrome | Status: COMPLETED